Minireviews
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Crit Care Med. Jun 9, 2024; 13(2): 94707
Published online Jun 9, 2024. doi: 10.5492/wjccm.v13.i2.94707
Serotonin syndrome controversies: A need for consensus
Sanjay Prakash, Chetsi S Shah, Anurag Prakash
Sanjay Prakash, Chetsi S Shah, Department of Neurology, Smt. B.K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth, Vadodara 391760, Gujarāt, India
Anurag Prakash, Medicine, Parul Institute of Medical Sciences and Research Centre, Parul University Waghodia, Vadodara 391760, India
Author contributions: Prakash S, Shah C, and Prakash A contributed to conceptualization, and data analysis; contributed to writing, original draft, writing, review and editing; all the authors have equally contributed towards conceptualization, data analysis, manuscript review, and final approval; all authors have read and agreed to the published version of the manuscript.
Conflict-of-interest statement: All the authors declare no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sanjay Prakash, DM, Professor, Department of Neurology, Smt. B.K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara 391760, Gujarāt, India. drprakashs@yahoo.co.in
Received: March 23, 2024
Revised: April 26, 2024
Accepted: May 11, 2024
Published online: June 9, 2024
Processing time: 71 Days and 23.2 Hours
Core Tip

Core Tip: Many recent papers have highlighted new developments in serotonin syndrome (SS). New clinical findings and clinical scenarios have emerged. Cases are now being reported from non-psychiatric and non-toxicological centers. SS can occur at therapeutic and stable doses. They create considerable diversity in various aspects of SS. Some experts, meanwhile, dismiss these recent advancements in SS. Because SS is a potentially fatal illness, there must be agreement on various issues of SS.